- Report
- January 2026
- 506 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 174 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 505 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 179 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 194 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 189 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 220 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 179 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 200 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 172 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 262 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 263 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 188 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 335 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 184 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 413 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 295 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 269 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 293 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 193 Pages
Global
From €5206EUR$5,850USD£4,520GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more